These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 1247336)

  • 21. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans.
    Sauter G; Berr F; Beuers U; Fischer S; Paumgartner G
    Hepatology; 1996 Jul; 24(1):123-6. PubMed ID: 8707250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile acid concentrations in the diagnosis of hepatobiliary disease in the cat.
    Center SA; Baldwin BH; Erb H; Tennant BC
    J Am Vet Med Assoc; 1986 Oct; 189(8):891-6. PubMed ID: 3771358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presentation and diagnosis of 100 patients with primary biliary cirrhosis.
    Sherlock S; Scheuer PJ
    N Engl J Med; 1973 Sep; 289(13):674-8. PubMed ID: 4580473
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum primary bile acids in Gilbert's syndrome.
    Roda A; Roda E; Sama C; Festi D; Aldini R; Morselli AM; Mazzella G; Barbara L
    Gastroenterology; 1982 Jan; 82(1):77-83. PubMed ID: 7053338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.
    Stiehl A; Earnest DL; Admirant WH
    Gastroenterology; 1975 Mar; 68(3):534-44. PubMed ID: 1112455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum bile acids in cholestasis of pregnancy.
    Laatikainen T; Ikonen E
    Obstet Gynecol; 1977 Sep; 50(3):313-8. PubMed ID: 896101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial changes in serum concentrations of individual bile salts in normal subjects and patients with acute viral hepatitis.
    Campbell CB; McGuffie C; Powell LW; Roberts RK; Stewart AW
    Am J Dig Dis; 1978 Jul; 23(7):599-608. PubMed ID: 685925
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis.
    Ono M; Sekiya C; Ohhira M; Ohhira M; Namiki M; Endo Y; Suzuki K; Matsuda Y; Taniguchi N
    J Lab Clin Med; 1991 Nov; 118(5):476-83. PubMed ID: 1682406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.
    Makino I; Hashimoto H; Shinozaki K; Yoshino K; Nakagawa S
    Gastroenterology; 1975 Mar; 68(3):545-53. PubMed ID: 1112456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary bile acid kinetics in patients with primary biliary cirrhosis and in normal subjects.
    Williams CN; MacDonald IA; Park-Dincsoy H
    Clin Invest Med; 1979; 2(1):29-40. PubMed ID: 509806
    [No Abstract]   [Full Text] [Related]  

  • 34. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver function and the diagnostic significance of conjugated cholic acid and chenodeoxycholic acid in serum of African patients with sickle cell disease.
    Bolarin DM
    Acta Trop; 1983 Dec; 40(4):359-64. PubMed ID: 6142634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical examination of serum bile acids for the diagnosis of hepatobiliary diseases].
    Fujiwara K
    Rinsho Byori; 1989 Oct; 37(10):1114-21. PubMed ID: 2601071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum bile acid analysis.
    Setchell KD; Matsui A
    Clin Chim Acta; 1983 Jan; 127(1):1-17. PubMed ID: 6337748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum primary bile acids in chronic alcoholic pancreatitis.
    Scuro LA; Angelini G; Vaona B; Fratton S; Tonon M; Antolini G; Micciolo R; Franchini CA; Cavallini G
    Hepatogastroenterology; 1983 Oct; 30(5):194-7. PubMed ID: 6642405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and urinary bile acids in patients with primary biliary cirrhosis.
    Samuelson K; Aly A; Johansson C; Norman A
    Scand J Gastroenterol; 1982 Jan; 17(1):121-8. PubMed ID: 7134826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK; Salen G; Abroon J
    Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.